Status | Study |
Completed |
Study Name: Supplemental Oxygen in Pulmonary Fibrosis Condition: Pulmonary Fibrosis Date: 2013-10-09 |
Recruiting |
Study Name: Pulmonary Fibrosis Contact Registry Condition: Pulmonary Fibrosis of Any Cause Primary Supporters/Caretakers o Date: 2013-08-31 |
Recruiting |
Study Name: Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab Condition: Pulmonary Fibrosis Date: 2013-08-01 Interventions: Drug: Bevacizumab Bevacizumab |
Active, not recruiting |
Study Name: Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2013-06-24 Interventions: Drug: FG-3019 |
Completed |
Study Name: The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis Condition: IDIOPATHIC PULMONARY FIBROSIS Date: 2012-10-23 |
Active, not recruiting |
Study Name: Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2011-12-20 Interventions: Behavioral: Pulmonary Rehabilitation Exercise Training in |
Completed |
Study Name: Pulmonary Fibrosis and Telomerase Mutation Study Condition: Pulmonary Fibrosis Date: 2011-12-13 |
Completed |
Study Name: A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2011-05-04 Interventions: Other: Placental MSC MSC will be derived from mothers donating their term placenta for clinical trial re |
Completed |
Study Name: Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study Condition: Idiopathic Pulmonary Fibrosis Date: 2009-05-14 Interventions: Drug: ACT-064992 (macitentan) |
Completed |
Study Name: A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Condition: Pulmonary Fibrosis Date: 2008-11-04 Interventions: Drug: Placebo Intravenous (IV) |